LymphedemaV1, PubMed, Checkpoint, bibRecord, 004D85

[Immunological observation on chyluric patients with heat-clearing and hemostatic drugs].

Identifieur interne : 004D85 ( PubMed/Checkpoint ); précédent : 004D84; suivant : 004D86

[Immunological observation on chyluric patients with heat-clearing and hemostatic drugs].

Auteurs : C. Xing ; X M Xing ; L. Xing

Source :

Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine [ 1003-5370 ] ; 1994.

RBID : pubmed:7719093

Descripteurs français

KwdFr :
- Adulte, Adulte d'âge moyen, Chyle, Déficit du Yin (immunologie), Déficit du Yin (traitement médicamenteux), Femelle, Filariose lymphatique (immunologie), Filariose lymphatique (traitement médicamenteux), Humains, Mâle, Médicaments issus de plantes chinoises (usage thérapeutique), Production d'anticorps (), Rapport CD4-CD8, Sous-populations de lymphocytes T (immunologie), Sujet âgé, Urine.
MESH :
- immunologie : Déficit du Yin, Filariose lymphatique, Sous-populations de lymphocytes T.
- traitement médicamenteux : Déficit du Yin, Filariose lymphatique.
- usage thérapeutique : Médicaments issus de plantes chinoises.
- Adulte, Adulte d'âge moyen, Chyle, Femelle, Humains, Mâle, Production d'anticorps, Rapport CD4-CD8, Sujet âgé, Urine.

English descriptors

KwdEn :
- Adult, Aged, Antibody Formation (drug effects), CD4-CD8 Ratio, Chyle, Drugs, Chinese Herbal (therapeutic use), Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (immunology), Female, Humans, Male, Middle Aged, T-Lymphocyte Subsets (immunology), Urine, Yin Deficiency (drug therapy), Yin Deficiency (immunology).
MESH :
- chemical , therapeutic use : Drugs, Chinese Herbal.
- drug effects : Antibody Formation.
- drug therapy : Elephantiasis, Filarial, Yin Deficiency.
- immunology : Elephantiasis, Filarial, T-Lymphocyte Subsets, Yin Deficiency.
- Adult, Aged, CD4-CD8 Ratio, Chyle, Female, Humans, Male, Middle Aged, Urine.

Abstract

In order to investigate the pathogenesis and therapeutic mechanism of chyluria, an experiment with a basic Heat-clearing and hemostatic prescription was conducted in treating 30 patients of chyluria. The result, 26 cases were cured completely. The cell-mediated and humoral immunity observation showed that OKT3 and OKT4 levels were commonly low in chyluric cases, and OKT8 as higher than normal value, the OKT4/OKT8 ratio was inverted before treatment. While OKT3 and OKT4 increased commonly, and OKT8 decreased with the OKT4/OKT8 ratio adjusted after treatment. Meanwhile, humoral immunity level was also commonly low before treatment, it increased after treatment.

PubMed: 7719093

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 005490
to stream PubMed, to step Curation: 005490

Links to Exploration step

pubmed:7719093

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Immunological observation on chyluric patients with heat-clearing and hemostatic drugs].</title>
<author><name sortKey="Xing, C" sort="Xing, C" uniqKey="Xing C" first="C" last="Xing">C. Xing</name>
<affiliation><nlm:affiliation>Jining Infectious Diseases Hospital, Shandong.</nlm:affiliation>
<wicri:noCountry code="subField">Shandong</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Xing, X M" sort="Xing, X M" uniqKey="Xing X" first="X M" last="Xing">X M Xing</name>
</author>
<author><name sortKey="Xing, L" sort="Xing, L" uniqKey="Xing L" first="L" last="Xing">L. Xing</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1994">1994</date>
<idno type="RBID">pubmed:7719093</idno>
<idno type="pmid">7719093</idno>
<idno type="wicri:Area/PubMed/Corpus">005490</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005490</idno>
<idno type="wicri:Area/PubMed/Curation">005490</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005490</idno>
<idno type="wicri:Area/PubMed/Checkpoint">005490</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">005490</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Immunological observation on chyluric patients with heat-clearing and hemostatic drugs].</title>
<author><name sortKey="Xing, C" sort="Xing, C" uniqKey="Xing C" first="C" last="Xing">C. Xing</name>
<affiliation><nlm:affiliation>Jining Infectious Diseases Hospital, Shandong.</nlm:affiliation>
<wicri:noCountry code="subField">Shandong</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Xing, X M" sort="Xing, X M" uniqKey="Xing X" first="X M" last="Xing">X M Xing</name>
</author>
<author><name sortKey="Xing, L" sort="Xing, L" uniqKey="Xing L" first="L" last="Xing">L. Xing</name>
</author>
</analytic>
<series><title level="j">Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine</title>
<idno type="ISSN">1003-5370</idno>
<imprint><date when="1994" type="published">1994</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Antibody Formation (drug effects)</term>
<term>CD4-CD8 Ratio</term>
<term>Chyle</term>
<term>Drugs, Chinese Herbal (therapeutic use)</term>
<term>Elephantiasis, Filarial (drug therapy)</term>
<term>Elephantiasis, Filarial (immunology)</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>T-Lymphocyte Subsets (immunology)</term>
<term>Urine</term>
<term>Yin Deficiency (drug therapy)</term>
<term>Yin Deficiency (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Chyle</term>
<term>Déficit du Yin (immunologie)</term>
<term>Déficit du Yin (traitement médicamenteux)</term>
<term>Femelle</term>
<term>Filariose lymphatique (immunologie)</term>
<term>Filariose lymphatique (traitement médicamenteux)</term>
<term>Humains</term>
<term>Mâle</term>
<term>Médicaments issus de plantes chinoises (usage thérapeutique)</term>
<term>Production d'anticorps ()</term>
<term>Rapport CD4-CD8</term>
<term>Sous-populations de lymphocytes T (immunologie)</term>
<term>Sujet âgé</term>
<term>Urine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Drugs, Chinese Herbal</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Antibody Formation</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>Yin Deficiency</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Déficit du Yin</term>
<term>Filariose lymphatique</term>
<term>Sous-populations de lymphocytes T</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>T-Lymphocyte Subsets</term>
<term>Yin Deficiency</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Déficit du Yin</term>
<term>Filariose lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Médicaments issus de plantes chinoises</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>CD4-CD8 Ratio</term>
<term>Chyle</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Urine</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Chyle</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Production d'anticorps</term>
<term>Rapport CD4-CD8</term>
<term>Sujet âgé</term>
<term>Urine</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">In order to investigate the pathogenesis and therapeutic mechanism of chyluria, an experiment with a basic Heat-clearing and hemostatic prescription was conducted in treating 30 patients of chyluria. The result, 26 cases were cured completely. The cell-mediated and humoral immunity observation showed that OKT3 and OKT4 levels were commonly low in chyluric cases, and OKT8 as higher than normal value, the OKT4/OKT8 ratio was inverted before treatment. While OKT3 and OKT4 increased commonly, and OKT8 decreased with the OKT4/OKT8 ratio adjusted after treatment. Meanwhile, humoral immunity level was also commonly low before treatment, it increased after treatment.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">7719093</PMID>
<DateCreated><Year>1995</Year>
<Month>05</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted><Year>1995</Year>
<Month>05</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised><Year>2016</Year>
<Month>10</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">1003-5370</ISSN>
<JournalIssue CitedMedium="Print"><Volume>14</Volume>
<Issue>10</Issue>
<PubDate><Year>1994</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine</Title>
<ISOAbbreviation>Zhongguo Zhong Xi Yi Jie He Za Zhi</ISOAbbreviation>
</Journal>
<ArticleTitle>[Immunological observation on chyluric patients with heat-clearing and hemostatic drugs].</ArticleTitle>
<Pagination><MedlinePgn>601-3</MedlinePgn>
</Pagination>
<Abstract><AbstractText>In order to investigate the pathogenesis and therapeutic mechanism of chyluria, an experiment with a basic Heat-clearing and hemostatic prescription was conducted in treating 30 patients of chyluria. The result, 26 cases were cured completely. The cell-mediated and humoral immunity observation showed that OKT3 and OKT4 levels were commonly low in chyluric cases, and OKT8 as higher than normal value, the OKT4/OKT8 ratio was inverted before treatment. While OKT3 and OKT4 increased commonly, and OKT8 decreased with the OKT4/OKT8 ratio adjusted after treatment. Meanwhile, humoral immunity level was also commonly low before treatment, it increased after treatment.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xing</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Jining Infectious Diseases Hospital, Shandong.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Xing</LastName>
<ForeName>X M</ForeName>
<Initials>XM</Initials>
</Author>
<Author ValidYN="Y"><LastName>Xing</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Author>
</AuthorList>
<Language>chi</Language>
<PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>China</Country>
<MedlineTA>Zhongguo Zhong Xi Yi Jie He Za Zhi</MedlineTA>
<NlmUniqueID>9211576</NlmUniqueID>
<ISSNLinking>1003-5370</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004365">Drugs, Chinese Herbal</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CitationSubset>X</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000917" MajorTopicYN="N">Antibody Formation</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016516" MajorTopicYN="N">CD4-CD8 Ratio</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002913" MajorTopicYN="Y">Chyle</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004365" MajorTopicYN="N">Drugs, Chinese Herbal</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016176" MajorTopicYN="N">T-Lymphocyte Subsets</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014556" MajorTopicYN="N">Urine</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016710" MajorTopicYN="N">Yin Deficiency</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1994</Year>
<Month>10</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1994</Year>
<Month>10</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1994</Year>
<Month>10</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">7719093</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list></list>
<tree><noCountry><name sortKey="Xing, C" sort="Xing, C" uniqKey="Xing C" first="C" last="Xing">C. Xing</name>
<name sortKey="Xing, L" sort="Xing, L" uniqKey="Xing L" first="L" last="Xing">L. Xing</name>
<name sortKey="Xing, X M" sort="Xing, X M" uniqKey="Xing X" first="X M" last="Xing">X M Xing</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004D85 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 004D85 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:7719093
   |texte=   [Immunological observation on chyluric patients with heat-clearing and hemostatic drugs].
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:7719093" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

[Immunological observation on chyluric patients with heat-clearing and hemostatic drugs].

[Immunological observation on chyluric patients with heat-clearing and hemostatic drugs].

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki